IMCD N.V. (IMCDY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
IMCD N.V. (IMCDY) trades at $46.68 with AI Score 41/100 (Grade C). IMCD N. V. Market cap: $5.51B, Sector: Basic materials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for IMCDY: IMCDY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IMCDY against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IMCDY: the 1 perspectives are evenly split.
How is this calculated? →IMCD N.V. (IMCDY) Materials & Commodity Exposure
IMCD N.V. is a global distributor of specialized chemicals and functional ingredients, connecting producers with diverse end markets including life sciences, personal care, and industrial materials. Headquartered in the Netherlands, the company leverages an extensive network across Europe, the Americas, Africa, and Asia-Pacific to provide comprehensive product solutions.
What Is the Investment Thesis for IMCDY?
IMCD N.V. operates as a crucial intermediary in the specialty chemicals distribution market, leveraging its extensive global network to connect producers with diverse end markets. The company's financial profile, characterized by a market capitalization of $5.51B, a P/E ratio of 24.39, and a dividend yield of 2.04%, indicates a mature yet growing business. Its gross margin of 17.7% and profit margin of 4.5% reflect its operational efficiency within the distribution model. Key value drivers include continued expansion into high-growth life sciences and personal care sectors, which demand specialized ingredients and technical expertise. The company's broad market access across multiple continents provides a resilient base for growth. However, as a distributor, IMCDY is subject to supplier and customer concentration risks, which require ongoing monitoring. Global economic conditions also significantly impact demand across its key end markets. Investors should evaluate IMCDY's ability to maintain strong supplier relationships and adapt to evolving regulatory landscapes and sustainability trends, which could serve as future growth catalysts.
Based on FMP financials and quantitative analysis
IMCDY Key Highlights
- Market Capitalization of $5.51B, indicating a significant presence in the specialty chemicals distribution sector.
- Price-to-Earnings (P/E) ratio of 24.39, reflecting investor valuation of its earnings potential within the industry.
- Gross Margin of 17.7%, demonstrating the company's efficiency in managing its cost of goods sold for specialized ingredients.
- Profit Margin of 4.5%, showcasing the company's ability to convert revenue into net income after all expenses.
- Dividend Yield of 2.04%, providing income to shareholders, consistent with a well-established, profitable enterprise.
Who Are IMCDY's Competitors?
IMCDY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SHWDY Resonac Holdings Corporation | $112.92 | +0.85% | $20.44B | — |
| BCHMF Bachem Holding AG | $87.34 | +0.00% | $6.54B | 46 |
| FUPBY Fuchs Petrolub SE | $11.21 | +3.19% | $5.88B | 44 |
| COIHY Croda International Plc | $19.99 | +0.15% | $5.58B | 48 |
| SOMMY Sumitomo Chemical Company, Limited | $16.51 | +2.67% | $5.45B | — |
| LWLG Lightwave Logic, Inc. | $7.37 | -9.30% | $1.13B | 69 |
| HGRAF HydroGraph Clean Power Inc. | $3.54 | -5.09% | $1.24B | 69 |
| COOSF Carbios SAS | $7.15 | +0.00% | $120.63M | 69 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IMCDY's Key Strengths?
- Extensive global distribution network providing broad market access.
- Diversified product portfolio catering to multiple high-growth end markets.
- Strong relationships with specialty chemical producers and local customers.
- Technical expertise and value-added services in complex chemical applications.
What Are IMCDY's Weaknesses?
- Potential exposure to supplier concentration risks.
- Vulnerability to customer concentration risks in specific regions or segments.
- Profit margins are typical for a distribution model, potentially lower than direct manufacturing.
- Reliance on global economic stability for sustained demand across end markets.
What Could Drive IMCDY Stock Higher?
- Continued expansion into high-growth life sciences markets, driven by increasing demand for specialized pharmaceutical and nutraceutical ingredients.
- Strategic acquisitions aimed at consolidating market share or entering new niche specialty chemical segments, enhancing product portfolio and geographic reach.
- Development and distribution of new sustainable and bio-based chemical solutions, capitalizing on global environmental trends and consumer demand.
- Further digitalization of its global distribution network, leading to enhanced operational efficiencies and improved customer service.
- Stronger economic growth in key emerging markets, driving increased industrial activity and demand for specialty chemicals.
What Are the Key Risks for IMCDY?
- Exposure to supplier concentration risks, where reliance on a limited number of key producers could impact product availability or pricing.
- Vulnerability to customer concentration risks, particularly if a significant portion of revenue is derived from a few large clients or specific end markets.
- Adverse fluctuations in global economic conditions, which could lead to reduced demand for specialty chemicals across IMCD N.V.'s diverse end markets.
- Changes in key supplier relationships, including contract renegotiations or termination, which could disrupt supply chains and impact profitability.
- Currency exchange rate volatility, particularly between the Euro and U.S. Dollar, affecting the reported financial performance and ADR value for U.S. investors.
What Are the Growth Opportunities for IMCDY?
- **Expansion in Life Sciences Segment:** The life sciences sector, encompassing pharmaceuticals, agrochemicals, and nutraceuticals, represents a significant growth avenue for IMCD N.V. This market segment is characterized by stringent regulatory requirements and a constant need for innovative, high-quality ingredients. IMCD's expertise in handling specialized compounds and its global distribution network position it to capture an increasing share of this market. The global pharmaceutical excipients market, for instance, is projected to grow, driven by new drug development and demand for advanced formulations, offering substantial opportunities for IMCD to expand its product portfolio and customer base in this high-value area.
- **Geographic Penetration in Emerging Markets:** IMCD N.V. already boasts an extensive global presence, but further penetration into rapidly developing economies, particularly in parts of Asia-Pacific, the Middle East, and Africa, presents a robust growth opportunity. These regions are experiencing industrialization, urbanization, and rising consumer spending, leading to increased demand for specialty chemicals across various applications. By establishing stronger local presences and tailoring product offerings to regional needs, IMCD can tap into new customer segments and achieve higher growth rates, leveraging its established logistical capabilities and market knowledge.
- **Focus on Sustainable and Bio-based Chemicals:** The global shift towards sustainability and environmental responsibility is driving demand for eco-friendly and bio-based chemical solutions. IMCD N.V., as a distributor, is well-positioned to capitalize on this trend by expanding its portfolio of sustainable ingredients, such as bio-polymers, green solvents, and naturally derived personal care components. This strategic focus aligns with evolving consumer preferences and regulatory pressures, allowing IMCD to serve clients seeking to reduce their environmental footprint and develop more sustainable products, thereby opening new market segments and strengthening existing relationships.
- **Strategic Mergers and Acquisitions (M&A):** Given its established market position, IMCD N.V. has the potential to pursue strategic mergers and acquisitions to consolidate market share, expand into niche specialty segments, or enhance its geographic reach. Acquiring smaller, specialized distributors or companies with unique product lines could immediately broaden IMCD's offerings, add technical expertise, and integrate new customer bases. Such inorganic growth strategies can accelerate market entry into new areas or strengthen its competitive advantage in existing ones, providing rapid scale and diversification in a fragmented industry.
- **Digitalization of Distribution and Supply Chain Optimization:** Enhancing digital capabilities across its distribution network and optimizing its supply chain represents a significant operational growth opportunity. Implementing advanced analytics, AI-driven demand forecasting, and e-commerce platforms can lead to greater efficiency, reduced operational costs, and improved customer experience. A more streamlined and transparent supply chain can also enhance IMCD's value proposition to both suppliers and customers, offering faster delivery, better inventory management, and more responsive service, thereby solidifying its competitive edge in a dynamic market.
What Opportunities Does IMCDY Have?
- Expansion into new geographic markets, particularly emerging economies.
- Increased demand for sustainable and bio-based chemical solutions.
- Strategic mergers and acquisitions to broaden product offerings or market share.
- Further penetration into the high-growth life sciences and personal care sectors.
- Digitalization of distribution processes to enhance efficiency and customer experience.
What Threats Does IMCDY Face?
- Fluctuations in global economic conditions impacting demand for specialty chemicals.
- Changes in supplier relationships or terms, affecting product availability and cost.
- Intensified competition from other distributors or direct sales by manufacturers.
- Regulatory changes in environmental or chemical safety standards.
- Currency exchange rate volatility impacting international revenues and costs.
What Are IMCDY's Competitive Advantages?
- Extensive global distribution network providing broad market access across multiple continents.
- Deep technical expertise and specialized knowledge in a wide range of chemical applications.
- Strong, established relationships with a diverse portfolio of specialty chemical producers.
- Value-added services, including formulation support and regulatory guidance, beyond basic distribution.
- Diversified product portfolio and end-market exposure, reducing reliance on any single industry segment.
What Does IMCDY Do?
Established in 1995 and headquartered in Rotterdam, the Netherlands, IMCD N.V. has evolved into a prominent international provider, marketer, and distributor of specialized chemicals and functional ingredients. The company's business model centers on acting as an intermediary, effectively connecting specialty chemical producers with a broad base of local customers across various industries. This extensive global presence spans key economic regions, including the Netherlands, the broader European region, the Middle East, Africa, both North and South America, and the entire Asia-Pacific. IMCD N.V. offers a comprehensive range of products meticulously curated to cater to diverse and critical sectors. These include the life sciences segment, encompassing pharmaceuticals, agrochemicals, and nutraceuticals, which demand high-purity and specialized compounds. The company also serves the personal care and cosmetics industry, providing ingredients essential for product formulation. Furthermore, IMCD N.V. is a vital supplier to industrial materials sectors, offering products like coatings, resins, and various additives that are crucial for manufacturing processes. Its reach extends to the food and beverage industry, where it supplies functional ingredients, and the energy sector, providing lubricants and fuel additives. The company's product portfolio is broad, encompassing a spectrum of compounds such as enzymes, surfactants, solvents, silicones, rheology modifiers, and increasingly, bio-based chemicals, reflecting its commitment to meeting evolving market demands and technological advancements. This diversified product offering and expansive geographic footprint underscore IMCD N.V.'s strategic position as a critical link in the global specialty chemicals supply chain.
What Products and Services Does IMCDY Offer?
- Distributes specialized chemicals and functional ingredients internationally.
- Connects specialty chemical producers with a diverse range of local customers.
- Serves the life sciences sector, including pharmaceuticals, agrochemicals, and nutraceuticals.
- Provides ingredients for personal care and cosmetics products.
- Supplies industrial materials like coatings, resins, and various additives.
- Offers products for the food and beverage industry.
- Distributes energy-related products such as lubricants and fuel additives.
- Manages a comprehensive portfolio including enzymes, surfactants, solvents, silicones, and bio-based chemicals.
How Does IMCDY Make Money?
- Acts as an intermediary, facilitating the global distribution of specialty chemicals from producers to end-users.
- Generates revenue through the sale of specialized chemicals and functional ingredients across diverse industries.
- Adds value through technical expertise, market knowledge, logistical services, and regulatory support.
- Leverages an extensive global network to provide broad market access and efficient supply chain solutions.
- Focuses on long-term relationships with both suppliers and customers to ensure consistent product flow and demand.
What Industry Does IMCDY Operate In?
IMCD N.V. operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector characterized by high-value, performance-driven products. The company's position as a distributor places it at a critical juncture between chemical manufacturers and diverse end-user industries. The specialty chemicals market is influenced by global economic growth, industrial production trends, and increasing demand for sustainable and high-performance materials. IMCD N.V. differentiates itself through its extensive global network and technical expertise, offering value-added services beyond mere distribution, such as formulation support and regulatory guidance. The competitive landscape includes other large-scale distributors as well as direct sales forces of major chemical producers. IMCD's strategy of broad market access and diversified product offerings across life sciences, industrial, and consumer segments helps mitigate reliance on any single market, positioning it to capitalize on various industry growth vectors.
Who Are IMCDY's Key Customers?
- Pharmaceutical manufacturers and agrochemical companies within the life sciences sector.
- Cosmetics and personal care product formulators.
- Industrial manufacturers requiring coatings, resins, and various additives.
- Food and beverage producers seeking functional ingredients.
- Energy companies utilizing lubricants and fuel additives.
Company Profile
IMCD N.V. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Rotterdam, NL. The company is led by CEO Marcus C. Jordan. IMCDY has traded publicly since 2019.
F-Score 4/9Financial Health
IMCD N.V.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.23 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 11%Key Financial Metrics
Return on equity for IMCD N.V. stands at 10.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.7%, showing how much profit it generates from its asset base. IMCDY trades at a trailing price-to-earnings ratio of 21.38, roughly in line with the Basic Materials sector average of ~22x. Its free cash flow yield is 6.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.73 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.7%, the inverse of the P/E and a quick read on earnings relative to price.
IMCDY Valuation & Market Position
With a $5.51B market cap, IMCD N.V. sits in the mid-cap segment of the market. Relative to its peer group, IMCDY's quantitative score of 41/100 is roughly in line with the peer average of 46/100.
FY2026 estForward Outlook
Wall Street analysts project IMCD N.V. revenue of about $5.00B for fiscal 2026, with EPS near $2.69. The estimate reflects 12 contributing analysts.
IMCDY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's growth potential, indicating that executives believe in the future trajectory of IMCD.
- Community sentiment has shifted positively, with discussions highlighting the company's strong market position and product diversification.
- Analysts have noted an increase in demand for specialty chemicals, which aligns well with IMCD's business model and offerings.
- Recent partnerships and collaborations have positioned IMCD favorably in the market, enhancing its competitive edge.
Bear Case
- Concerns have arisen regarding potential supply chain disruptions that could affect IMCD's ability to meet demand.
- Some community members express skepticism about the company's valuation, suggesting it may be overhyped given current market conditions.
- Recent geopolitical tensions could impact IMCD's operations in certain regions, raising uncertainty among investors.
- Market sentiment has shown signs of caution as broader economic indicators suggest potential headwinds for the specialty chemicals sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IMCDY Latest News
No recent news available for IMCDY.
IMCDY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IMCDY.
Price Targets
Wall Street price target analysis for IMCDY.
IMCDY MoonshotScore
What does this score mean?
The MoonshotScore rates IMCDY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Marcus C. Jordan
CEO
Marcus C. Jordan serves as the CEO of IMCD N.V., overseeing a global workforce of 5126 employees. Specific details regarding his educational background, prior career history, and previous executive roles are not provided in the available source data. In his capacity as CEO, Mr. Jordan is responsible for the strategic direction and operational management of IMCD N.V.'s extensive international distribution network for specialized chemicals and functional ingredients. His leadership is central to the company's efforts in connecting producers with diverse end markets across multiple continents.
Track Record: Specific achievements and strategic decisions under Marcus C. Jordan's direct leadership are not detailed in the provided information. However, as CEO, he is responsible for guiding IMCD N.V.'s global operations, which encompass significant market capitalization and a broad international footprint. His tenure involves managing the company's growth initiatives, maintaining key supplier and customer relationships, and navigating the complexities of the global specialty chemicals distribution market, overseeing the company's performance metrics such as its profit and gross margins.
IMCD N.V. ADR Information Unsponsored
IMCDY is an American Depositary Receipt (ADR) Level 1, which allows U.S. investors to trade shares of IMCD N.V., a non-U.S. company, on the U.S. over-the-counter (OTC) market. This particular ADR level is the simplest, typically unsponsored, meaning the foreign company does not directly participate in the issuance. It facilitates U.S. investor access to foreign securities without requiring direct trading on foreign exchanges, with the underlying shares held by a depositary bank.
- Home Market Ticker: Rotterdam, NL
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: IMCD
IMCDY OTC Market Information
IMCDY trades on the OTC market under the 'OTC Other' tier. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or do not qualify for the 'Pink Open Market' due to lack of current information. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which have strict listing standards regarding financial reporting, corporate governance, and minimum share prices, 'OTC Other' companies have minimal to no public disclosure requirements. This can result in less transparency and higher risk for investors compared to exchange-listed securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public disclosure and transparency due to 'OTC Other' tier classification.
- Potentially lower trading volume and wider bid-ask spreads, leading to reduced liquidity.
- Increased price volatility due to less market depth and fewer institutional participants.
- Limited analyst coverage and institutional interest compared to exchange-listed stocks.
- Greater difficulty in obtaining reliable financial and operational information for investment decisions.
- Verify any available financial reports directly from the company or its home market exchange.
- Assess the company's business model and competitive landscape thoroughly, given limited U.S. regulatory oversight.
- Evaluate the liquidity of the stock by observing recent trading volumes and bid-ask spreads.
- Understand the management team's background and track record, if information is available.
- Research the company's home country regulatory environment and disclosure requirements.
- Consider the potential impact of currency fluctuations on the ADR's value and dividends.
- Consult with a financial advisor experienced in international and OTC investments.
- IMCD N.V. is an established company, founded in 1995, indicating a long operational history.
- The company has an extensive global presence across multiple continents, suggesting a robust operational scale.
- Its clear business model as a distributor of specialized chemicals provides a tangible economic purpose.
- The company's primary listing on a home market exchange (Rotterdam, NL) suggests adherence to its local regulatory standards.
- A significant market capitalization of $5.51B indicates a substantial and recognized entity.
IMCDY Basic Materials Stock FAQ
What does IMCD N.V. do?
IMCD N.V. operates as a leading international provider, marketer, and distributor of specialized chemicals and functional ingredients. Its core business model involves acting as a critical intermediary, connecting specialty chemical producers with a diverse array of local customers across various industries. The company's extensive product portfolio caters to sectors such as life sciences (pharmaceuticals, agrochemicals, nutraceuticals), personal care and cosmetics, industrial materials (coatings, resins), food and beverage, and energy (lubricants, fuel additives). With a global presence spanning Europe, the Americas, Africa, and Asia-Pacific, IMCD N.V. leverages its network to provide broad market access and value-added services, including technical expertise and logistical solutions.
How does IMCD N.V. compare to competitors in its industry?
IMCD N.V. distinguishes itself in the specialty chemicals distribution industry through its extensive global network and diversified end-market exposure. Unlike direct manufacturers such as Resonac Holdings Corporation or Sumitomo Chemical Company, Limited, IMCD N.V. focuses on the distribution and value-added services, connecting producers with a broad customer base. While companies like Croda International Plc also operate in specialty chemicals, IMCD's strength lies in its comprehensive distribution model rather than proprietary manufacturing. Compared to other distributors, IMCD's broad geographic reach across Europe, the Americas, Africa, and Asia-Pacific, coupled with its technical expertise in various applications, provides a competitive advantage in serving a wide range of industries from pharmaceuticals to industrial materials.
What are the key financial metrics investors watch for IMCDY?
Investors monitoring IMCDY typically focus on several key financial metrics to assess its performance and valuation within the specialty chemicals distribution sector. The Gross Margin of 17.7% and Profit Margin of 4.5% are crucial for understanding the company's operational efficiency and ability to generate profit from its distribution activities. Given its role as an intermediary, these margins reflect its pricing power and cost management. The P/E ratio of 24.39 provides insight into how the market values IMCD N.V.'s earnings relative to its peers. Additionally, the Dividend Yield of 2.04% is important for income-focused investors, while the Beta of 0.94 indicates its sensitivity to broader market movements, suggesting slightly lower volatility than the overall market.
What are the key factors to evaluate for IMCDY?
IMCD N.V. (IMCDY) holds an AI score of 41/100 (low). Not financial advice.
How frequently does IMCDY data refresh on this page?
IMCDY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IMCDY's recent stock price performance?
IMCD N.V. (IMCDY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Extensive global distribution network providing broad market access. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IMCDY overvalued or undervalued right now?
Valuing IMCD N.V. (IMCDY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IMCDY?
Before investing in IMCD N.V. (IMCDY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Specific background details for CEO Marcus C. Jordan were not provided in the source data.
- Specific tax implications for ADR holders (foreign dividend withholding tax rate) were not provided.
- The disclosure status for IMCDY on the OTC market is noted as 'Unknown' in the source data.